Nielsen Holdings N.V. (NYSE:NLSN) recently announced that Valcon Acquisition Holding (Luxembourg), the selling stockholder, has priced a secondary offering of 8 million shares. The offering has been priced at $45.21 per share. The underwriters of the offering have an option to purchase up to 1,200,000 additional shares from the selling stockholder. Nielsen Holdings N.V. (NYSE:NLSN) in last trading activity increased 1.17% to close at $43.17. Company weekly performance is -3.62% while its quarterly performance stands at -3.90%. Nielsen Holdings N.V. (NYSE:NLSN) is -11.50% away from its 52 week high.
KVH Industries Inc. (NASDAQ:KVHI) chief executive officer, Martin Kits van Heyningen, spoke at the 36th Annual Institutional Investors Conference in Orlando, Florida, on Wednesday, March 4, 2015. On last trading day KVH Industries Inc. (NASDAQ:KVHI) increased 1.09% to close at $12.98. Its volatility for the week is 2.23% while volatility for the month is 1.90%. KVHI’s sales growth for past 5 years was 14.50% and its EPS growth for past 5 years was 7.40%. KVH Industries Inc. (NASDAQ:KVHI) monthly performance is 2.20%.
Bristol-Myers Squibb Company (NYSE:BMY) announced that the resubmitted new drug application (NDA) for daclatasvir, an investigational NS5A replication complex inhibitor, has been accepted for review by the U.S. Food and Drug Administration (FDA) for use in combination with sofosbuvir for the treatment of chronic hepatitis C (HCV) genotype 3. The original NDA has been amended to include data from the Phase III ALLY-3 trial, which showed high cure rates for the combination, with sustained virologic response 12 weeks after treatment (SVR12) in 90% of treatment-naïve and 86% of treatment-experienced genotype 3 HCV patients. SVR12 rates were higher (96%) in non-cirrhotic genotype 3 patients, regardless of treatment history. On Thursday shares of Bristol-Myers Squibb Company (NYSE:BMY) closed at $66.65. Company’s sales growth for last 5 years was -3.30% and EPS growth for next 5 years is recorded as 16.21%.
FXCM Inc. (NYSE:FXCM), announced for the quarter ended December 31, 2014, U.S. GAAP revenues of $134.7 million, compared to $113.3 million for the quarter ended December 31, 2013, an increase of 19%. U.S. GAAP net income attributable to FXCM Inc. was $15.8 million for the fourth quarter 2014 or $0.35 per fully diluted share, compared to U.S. GAAP net income of $3.0 million or $0.08 per fully diluted share for the fourth quarter 2013. FXCM Inc. (NYSE:FXCM) in last trading activity increased 1.42% to close at $2.15. Company weekly performance is 1.90% while its quarterly performance stands at -87.22%. FXCM Inc. (NYSE:FXCM) is -87.63% away from its 52 week high.
Walt Disney Co. (NYSE:DIS) said that, at the 2015 Annual Meeting, its shareholders elected all 10 members of the Board of Directors and supported Board recommendations on the Company’s auditor and the advisory vote on executive compensation, based on preliminary results. On last trading day The Walt Disney Company (NYSE:DIS) increased 4.16% to close at $107.17. Its volatility for the week is 1.74% while volatility for the month is 1.29%. DIS’s sales growth for past 5 years was 6.20% and its EPS growth for past 5 years was 19.30%. The Walt Disney Company (NYSE:DIS) monthly performance is 5.15%.